Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEveryman Media Regulatory News (EMAN)

Share Price Information for Everyman Media (EMAN)

Share Price is delayed by 15 minutes
Get Live Data
37.00    0.00 (0.00%)
Bid:
36.00
Ask:
38.00
Spread: 2.00 (5.556%)
Market Cap: £33.82m
EMAN Live PriceLast checked at - London Stock Exchange

Intraday Everyman Media Share Chart

Trading Update

23 Jan 2024 07:00

RNS Number : 5315A
Everyman Media Group PLC
23 January 2024
 

23 January 2024

Everyman Media Group PLC

("Everyman" or the "Group")

 

Trading Update

Everyman Media Group Plc (AIM: EMAN) is pleased to announce the following unaudited trading update for the 52-week period ended 28 December 2023.

Financial Highlights

· Group revenue up 16.7% to approximately £90.9m (2022: £77.9m1 with VAT benefit removed).

· Group EBITDA2 up 19.1% to approximately £16.2m (2022: £13.6m1 with VAT benefit removed).

· Market share increased to 4.8% (2022: 4.5%).

· Agreed a new three-year loan facility of £35m with Barclays Bank Plc and National Westminster Bank Plc, ensuring that the Group is soundly financially structured and well positioned to take advantage of opportunities moving forward.

· The Group's performance in H2 2023 was marginally affected by the well-documented WGA and SAG-AFTRA strikes, which led to certain key titles moving to 2024. The Board is pleased however to re-confirm market expectations for 2024 and has confidence in the prospects of the business moving forward.

Operational Highlights

· Four new venues were opened in the year, in Marlow, Salisbury, Northallerton and Plymouth.

· Acquisition of the Tivoli venues in Bath and Cheltenham from Empire Cinemas Limited on 15 December 2023.

· The Group now operates 44 venues with a total of 152 screens (2022: 38 venues with a total of 130 screens).

· Paid for average ticket price3 of £11.65, a 3.2% increase versus the prior year (2022: £11.29).

· Food and beverage spend3 per head of £10.29, a 10.2% increase versus the prior year (2022: £9.34).

Current Trading and Outlook

· The Group has confidence in the continuously improving film slate during 2024. Titles include Wicked, Despicable Me 4, Paddington in Peru, Joker: Folie à Deux, Inside Out 2, Mufasa: The Lion King, Dune: Part II and an untitled Gladiator sequel.

· The Group remains committed to measured organic expansion with excellent opportunities available for new sites. New openings include Bury St Edmunds in Q1 2024, Durham and Stratford (London) in Q3 2024 and Cambridge in Q4 2024. Further, as demonstrated with Tivoli, the Company will continue to consider opportunistic acquisitions.

Alex Scrimgeour, Chief Executive Officer of Everyman Media Group Plc, said:

"We have delivered robust, double-digit growth in both revenue and EBITDA against a challenging economic backdrop, delays to new openings and both writers' and actors' strikes. Further operational progress has been made with improvements in all key metrics, illustrating that our proposition remains as relevant as ever.

I would like to take this opportunity to thank our incredible venue teams and head office without whom the positive achievements of this year would not have been possible."

12022 reported Revenue (£78.8m) and EBITDA (£14.5m) both benefitted from £0.9m Temporarily Reduced Rate of VAT.

2Adjusted for pre-opening costs, acquisition expenses, exceptional costs, depreciation, amortization and share based payments.

3Paid for average ticket price and food and beverage spend per head have been adjusted to remove the benefit of the Temporarily Reduced Rate of VAT in 2022 in order to provide a like-for-like comparison.

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended) ("UK MAR").

 

For further information, please contact:

 

Everyman Media Group plc

Tel: 020 3145 0500

Alex Scrimgeour, Chief Executive

Will Worsdell, Finance Director

 

Canaccord Genuity Limited (NOMAD and Broker)

Tel: 020 7523 8000

Bobbie Hilliam

Harry Pardoe

Alma PR (Financial PR Advisor)

Tel: 020 3405 0205

Rebecca Sanders-Hewett

David Ison

 

Joe Pederzolli

 

About Everyman Media Group PLC:

 

Everyman is the fourth largest cinema business in the UK by number of venues, and is a premium, high growth leisure brand. Everyman operates a growing estate of venues across the UK, with an emphasis on providing first class cinema and hospitality.

 

Everyman is redefining cinema. It focuses on venue and experience as key competitive strengths, with a unique proposition:

· Intimate and atmospheric venues, which become a destination in their own right

· An emphasis on a strong quality food and drink menu prepared in-house

· A broad range of well-curated programming content, from mainstream and independent films to theatre and live concert streams, appealing to a diverse range of audiences

· Motivated and welcoming teams

 

For more information visit http://investors.everymancinema.com/

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQKBBKDBKBDDB
Date   Source Headline
2nd Jun 20268:47 amRNSPDMR Shareholding
29th May 202611:56 amRNSPDMR Dealing
27th May 20269:23 amRNSPosting of Annual Report and Notice of AGM
21st May 20265:04 pmRNSPDMR Shareholding
6th May 20267:00 amRNSExercise of Options and Total Voting Rights
5th May 20267:00 amRNSExercise of Options and Total Voting Rights
5th May 20267:00 amRNSPDMR Dealing
28th Apr 20267:00 amRNSFull Year Results to 1 January 2026
21st Apr 20267:00 amRNSBoard Update and Notice of Results
1st Apr 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 202610:58 amRNSDirector/PDMR Shareholding
26th Mar 20265:08 pmRNSNotification of major holdings
26th Mar 20265:01 pmRNSNotification of major holdings
23rd Mar 20261:26 pmRNSDirector/PDMR Shareholding
16th Mar 20269:04 amRNSDirector/PDMR Shareholding
16th Mar 20269:04 amRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSGrant of Options
11th Mar 20267:00 amRNSGrant of Options
6th Mar 20267:00 amRNSDirector/PDMR Shareholding
19th Feb 20267:00 amRNSDirector/PDMR Shareholding
17th Feb 20267:00 amRNSDirector/PDMR Shareholding
6th Feb 20267:00 amRNSBoard Appointments
27th Jan 20267:00 amRNSTrading Update
29th Dec 20257:00 amRNSBoard change
29th Dec 20257:00 amRNSBoard change
16th Dec 20252:47 pmRNSNotification of major holdings
15th Dec 20257:00 amRNSBoard change
10th Dec 20257:00 amRNSTrading Update
24th Sep 20257:02 amRNSChange of Options Terms
24th Sep 20257:01 amRNSAppointment of Non-Executive Director
24th Sep 20257:00 amRNSInterim Results
28th Jul 20257:00 amRNSTrading Update
19th Jun 20251:24 pmRNSResult of AGM
20th May 20257:00 amRNSPosting of Annual Report and Notice of AGM
9th May 20257:00 amRNSDirector / PDMR Shareholding
15th Apr 20257:01 amRNSGrant of Options
15th Apr 20257:00 amRNSPreliminary Results to 02 January 2025
2nd Apr 20257:00 amRNSNotice of Results
17th Jan 20257:00 amRNSTrading Update
25th Sep 20247:00 amRNSInterim Results
16th Aug 20247:00 amRNSExercise of Options and Total Voting Rights
1st Aug 20247:00 amRNSDirector/PDMR Shareholding
25th Jul 20247:00 amRNSTrading Update and Notice of Results
13th Jun 20243:45 pmRNSResult of AGM
17th May 20247:00 amRNSNotice of AGM
18th Apr 20249:17 amRNSDirector/PDMR Shareholding
17th Apr 20247:00 amRNSGrant of Options
16th Apr 20247:00 amRNSFinal Results to 28 December 2023
28th Mar 20247:00 amRNSNotice of Results and Investor Presentation
9th Feb 202412:45 pmRNSCorrection: Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.